186 related articles for article (PubMed ID: 6119771)
1. Placebo controlled studies with ranitidine in duodenal ulcer.
Dobrilla G; Barbara L; Bianchi Porro G; Felder M; Mazzacca G; Miglioli L; Pera A; Petrillo M; Sabbatini F; Verme G
Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
Dobrilla G; de Pretis G; Felder M; Chilovi F
Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
[TBL] [Abstract][Full Text] [Related]
3. Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Hepatogastroenterology; 1981 Aug; 28(4):216-7. PubMed ID: 6115807
[TBL] [Abstract][Full Text] [Related]
4. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
6. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
Moshal MG; Spitaels JM; Khan F
Scand J Gastroenterol Suppl; 1981 Jun; 69():129-31. PubMed ID: 6119777
[TBL] [Abstract][Full Text] [Related]
7. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist.
Berstad A; Kett K; Aadland E; Carlsen E; Frislid K; Saxhaug K; Kruse-Jensen A
Scand J Gastroenterol; 1980; 15(5):637-9. PubMed ID: 6108607
[TBL] [Abstract][Full Text] [Related]
8. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[TBL] [Abstract][Full Text] [Related]
9. Clinical and endocrine aspects of treatment with ranitidine.
Boyd EJ; Peden NR; Browning MC; Saunders JH; Wormsley KG
Scand J Gastroenterol Suppl; 1981 Jun; 69():81-3. PubMed ID: 6119787
[TBL] [Abstract][Full Text] [Related]
10. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine: a pilot study in Japan.
Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of twice-daily ranitidine and placebo in the treatment of duodenal ulcer--a multicentre study in the United Kingdom.
Lee FI; Fielding JD; MacKay C; Mitchell K; Mohammed R; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Stone WD; Orchard RT; Calcraft BJ; Rose JA
Hepatogastroenterology; 1982 Jun; 29(3):127-9. PubMed ID: 6125463
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
Hüttemann W
Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
[TBL] [Abstract][Full Text] [Related]
14. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
Pace F; Colombo E; Ferrara A; Prada A; Rocca F; Bianchi Porro G
Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
Di Mario F; Battaglia G; Naccarato R; D'Angelo A; Saggioro A; Da Broi GL; Vezzadini P; Bianchi Porro G
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():62-5. PubMed ID: 1982108
[TBL] [Abstract][Full Text] [Related]
16. Controlled trial with ranitidine in the treatment of peptic ulcer.
Nelis GF
Neth J Med; 1981; 24(6):224-8. PubMed ID: 6119631
[No Abstract] [Full Text] [Related]
17. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
18. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
[TBL] [Abstract][Full Text] [Related]
19. Effect of ranitidine on healing of peptic ulcer: a 2-month study.
Leroux P; Farley A; Archambault A; Pilon G; Gosselin D; Paré P; Lévesque D; Sherbaniuk R; Thomson AB
Am J Gastroenterol; 1983 Apr; 78(4):227-30. PubMed ID: 6301262
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]